Zoran Zdraveski's most recent trade in Tscan Therapeutics Inc was a trade of 164,686 Voting Common Stock done at an average price of $5.8 . Disclosure was reported to the exchange on Aug. 23, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tscan Therapeutics Inc | Zoran Zdraveski | See Remarks | Sale of securities on an exchange or to another person at price $ 5.78 per share. | 23 Aug 2024 | 164,686 | 4,716 | - | 5.8 | 952,116 | Voting Common Stock |
| Tscan Therapeutics Inc | Zoran Zdraveski | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.49 per share. | 23 Aug 2024 | 64,166 | 169,402 | - | 2.5 | 159,773 | Voting Common Stock |
| Tscan Therapeutics Inc | Zoran Zdraveski | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2024 | 64,166 | 365,834 | - | - | Stock Option (Right to Buy) | |
| Tscan Therapeutics Inc | Zoran Zdraveski | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.85 per share. | 23 Aug 2024 | 54,895 | 67,111 | - | 4.9 | 266,241 | Voting Common Stock |
| Tscan Therapeutics Inc | Zoran Zdraveski | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2024 | 54,895 | 30,105 | - | - | Stock Option (Right to Buy) | |
| Tscan Therapeutics Inc | Zoran Zdraveski | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.27 per share. | 23 Aug 2024 | 25,000 | 92,111 | - | 3.3 | 81,750 | Voting Common Stock |
| Tscan Therapeutics Inc | Zoran Zdraveski | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Tscan Therapeutics Inc | Zoran Zdraveski | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.81 per share. | 23 Aug 2024 | 13,125 | 105,236 | - | 1.8 | 23,756 | Voting Common Stock |
| Tscan Therapeutics Inc | Zoran Zdraveski | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2024 | 13,125 | 21,875 | - | - | Stock Option (Right to Buy) | |
| Tscan Therapeutics Inc | Zoran Zdraveski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Tscan Therapeutics Inc | Zoran Zdraveski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 52,500 | 52,500 | - | - | Stock Option (Right to Buy) | |
| Tscan Therapeutics Inc | Zoran Zdraveski | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 430,000 | 430,000 | - | - | Stock Option (Right to Buy) | |
| Tscan Therapeutics Inc | Zoran Zdraveski | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Tscan Therapeutics Inc | Zoran Zdraveski | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Tscan Therapeutics Inc | Zoran Zdraveski | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 85,000 | 85,000 | - | - | Stock Option (Right to Buy) |